A nurse is caring for a client who has hypertension and nephropathy due to type 2 diabetes mellitus. The nurse should expect to administer which of the following medications to slow the progression of the nephropathy?
Sitagliptin.
Glipizide.
Metoprolol.
Losartan.
The Correct Answer is D
Choice A rationale
Sitagliptin is a DPP-4 inhibitor used to manage blood sugar levels in type 2 diabetes but does not specifically slow the progression of nephropathy.
Choice B rationale
Glipizide is a sulfonylurea that helps control blood sugar levels but does not have a direct effect on slowing nephropathy progression.
Choice C rationale
Metoprolol is a beta-blocker used to manage hypertension but does not specifically target nephropathy progression.
Choice D rationale
Losartan is an angiotensin II receptor blocker (ARB) that helps manage hypertension and has been shown to slow the progression of nephropathy in patients with type 2 diabetes.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is ["A","B","C"]
Explanation
Choice A rationale
Peripheral edema is a common adverse effect of verapamil. It occurs due to the vasodilatory effects of the medication, which can cause fluid retention in the extremities.
Choice B rationale
Bradycardia is an adverse effect of verapamil. It occurs because verapamil slows down the heart rate by blocking calcium channels in the heart.
Choice C rationale
Constipation is a common adverse effect of verapamil. It occurs due to the medication’s effect on smooth muscle relaxation, which can slow down gastrointestinal motility.
Choice D rationale
Reports of blurred vision are not a common adverse effect of verapamil. Blurred vision is not typically associated with this medication.
Choice E rationale
Reports of insomnia are not a common adverse effect of verapamil. Insomnia is not typically associated with this medication.
Correct Answer is C
Explanation
Choice A rationale
Incorrect packaging, such as a topical medication packaged as an oral medication, can lead to medication errors. However, it is not the most frequent cause of fatal medication errors. Packaging errors are relatively rare and usually caught before administration.
Choice B rationale
Delivery device problems, such as an infusion pump malfunction, can cause medication errors. These errors can be serious but are not the most frequent cause of fatal medication errors. Device malfunctions are often detected and corrected by healthcare professionals.
Choice C rationale
Name confusion between two medications with similar sounding names is the most frequent cause of fatal medication errors. This type of error occurs when medications with similar names are confused, leading to the administration of the wrong drug. This can have serious and sometimes fatal consequences.
Choice D rationale
Incorrect labeling of a medication dispensed by the pharmacy can lead to medication errors. While labeling errors are a significant concern, they are not the most frequent cause of fatal medication errors. These errors are often identified and corrected before administration.